Related Experiment Videos
Bcl-XL and Bcl-2 repress a common pathway of cell death
D T Chao1, G P Linette, L H Boise
1Howard Hughes Medical Institute, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract:
The effect of Bcl-xL upon the developmental death of T cells was assessed by generating transgenic mice that expressed Bcl-xL within all thymocyte subsets. Bcl-xL protected thymocytes from a variety of apoptotic stimuli, including gamma irradiation, glucocorticoids, and anti-CD3 treatment. Bcl-xL altered thymocyte maturation, resulting in increased numbers of CD3int/hi and CD4-8+ thymocytes. Overall, the phenotype of Bcl-xL transgenics was essentially indistinguishable from a Bcl-2 transgenic model. Overexpression of Bcl-xL or Bcl-2 resulted in the down-regulation of the other molecule, providing further evidence of their reciprocal regulation. In a genetic test of redundancy, the Bcl-xL transgene rescued mature T cells in Bcl-2 null mice. Immunoprecipitation indicated that Bcl-xL, like Bcl-2, heterodimerized with the death-promoting molecule Bax in thymocytes. This in vivo model argues that Bcl-xL, like Bcl-2, functions in a common pathway to repress cell death.
Insights
Bcl-xL protein protects T cells from programmed cell death and aids their maturation. This study shows Bcl-xL and Bcl-2 proteins work together in a common pathway to prevent cell death during T cell development.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- T cell development is a critical process involving programmed cell death (apoptosis) to eliminate self-reactive or immature cells.
- The BCL2 family of proteins plays a crucial role in regulating apoptosis.
- Bcl-xL is a pro-survival member of the BCL2 family, but its specific role in T cell development requires further elucidation.
Purpose of the Study:
- To investigate the function of Bcl-xL in T cell development and survival.
- To compare the effects of Bcl-xL with those of Bcl-2 in T cell development.
- To determine if Bcl-xL and Bcl-2 function in a common apoptotic pathway.
Main Methods:
- Generation of transgenic mice expressing Bcl-xL in all thymocyte subsets.
- Assessment of thymocyte survival under various apoptotic stimuli (gamma irradiation, glucocorticoids, anti-CD3 treatment).
- Flow cytometry analysis to evaluate thymocyte maturation.
- Genetic rescue experiments in Bcl-2 null mice.
- Immunoprecipitation to study protein interactions.
Main Results:
- Bcl-xL expression protected thymocytes from multiple apoptotic stimuli.
- Bcl-xL altered thymocyte maturation, increasing specific subsets (CD3int/hi and CD4-8+).
- The phenotype of Bcl-xL transgenic mice was similar to Bcl-2 transgenic mice.
- Overexpression of Bcl-xL or Bcl-2 led to down-regulation of the other, indicating reciprocal regulation.
- Bcl-xL transgene rescued mature T cells in Bcl-2 null mice.
- Bcl-xL, like Bcl-2, heterodimerized with Bax in thymocytes.
Conclusions:
- Bcl-xL is a key regulator of T cell survival and development, functioning similarly to Bcl-2.
- Bcl-xL and Bcl-2 likely operate within a common pathway to inhibit apoptosis during T cell development.
- These findings highlight the crucial role of the BCL2 family in maintaining T cell homeostasis.